HAIKOU CITY, China, Nov. 8, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, plans to present at three investment conferences during the month of November 2010. Details for the conferences are as follows:
|
Conference: |
Brean Murray, Carret & Co. 2010 China Growth Conference |
|
|
Date: |
November 17, 2010 – November 18, 2010 |
|
|
Presentation time: |
Wednesday, November 17, 2010 at 11:20 a.m. EST |
|
|
Location: |
The Millennium Broadway Hotel |
|
|
145 West 44th Street |
||
|
New York, NY 10036 |
||
|
Conference: |
Lazard Capital Markets 7th Annual Healthcare Conference |
|
|
Date: |
November 16, 2010 – November 17, 2010 |
|
|
Presentation time: |
Wednesday, November 17, 2010 at 3:15 p.m. EST |
|
|
Location: |
The St. Regis Hotel |
|
|
2 East 55th Street, |
||
|
New York, NY 10022 |
||
|
Conference: |
The 4th Annual Maxim Group Growth Conference |
|
|
Date: |
November 18, 2010 |
|
|
Presentation time: |
Thursday, November 18, 2010 at 9:30 a.m. EST |
|
|
Location |
Grand Hyatt New York Hotel |
|
|
109 East 42nd Street at Grand Central Terminal, |
||
|
New York, NY 10017 |
||
Mr. Waung and the Company's Vice President, Mr. Sam Hsing Dong, will be available to meet with investors throughout these conferences. Please contact your respective institutional sales representatives for further details.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com.
|
Contact: |
|
|
China Pharma Holdings, Inc. |
|
|
Phone: +86-898-6681-1730 (China) |
|
|
Email: hps@chinapharmaholdings.com |
|
|
CCG Investor Relations |
|
|
Kalle Ahl, CFA, Account Manager |
|
|
Phone: +1-646-833-3417 (New York) |
|
|
Email: kalle.ahl@ccgir.com |
|
|
Vivian Chen, Sr. Market Intelligence Exec. |
|
|
Phone: +1-(646)-701-7445(New York) |
|
|
Email: vivian.chen@ccgir.com |
|